β2-1 Fructans have a bifidogenic effect in healthy middle-aged human subjects but do not alter immune responses examined in the absence of an in vivo immune challenge: Results from a randomised controlled trial

British Journal of Nutrition

Volumn 108, Issue 10, 2012, Pages 1818-1828

  Lomax, Amy R ^a   Cheung, Lydia V Y ^a   Tuohy, Kieran M ^b,c   Noakes, Paul S ^a   Miles, Elizabeth A ^a   Calder, Philip C ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

^c RESEARCH AND INNOVATION CENTRE   (Italy)

Author keywords

2 1 Fructans; Bifidobacteria; Immune function; Prebiotics

Indexed keywords

BETA2 1 FRUCTAN; CYTOKINE; IMMUNOGLOBULIN A; MALTODEXTRIN; ORAFTI SYNERGY1; PHORBOL ESTER; PLACEBO; PREBIOTIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL COUNT; BIFIDOBACTERIUM; BLOATING; BLOOD ANALYSIS; BODY MASS; CONSTIPATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; ESCHERICHIA COLI; FECES ANALYSIS; FECES MICROFLORA; FEMALE; FLATULENCE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IN VIVO STUDY; INTESTINE MOTILITY; LOOSE FECES; LYMPHOCYTE PROLIFERATION; MALE; MIDDLE AGED; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NORMAL HUMAN; PATIENT COMPLIANCE; PHAGOCYTOSIS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY BURST; SALIVA ANALYSIS; SELF REPORT; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BIOLOGICAL MARKERS; CELL PROLIFERATION; CYTOKINES; FECES; FEMALE; FRUCTANS; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULINS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGED; POLYSACCHARIDES; PREBIOTICS; SALIVA;

ESCHERICHIA COLI;

EID: 84869993071     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511007276     Document Type: Article

References (35)

1. Roberfroid M, Gibson GR, Hoyles L, et al. (2010) Prebiotic effects: metabolic and health benefits. Br J Nutr 104, Suppl. 2, S1-S63.
2. Guigoz Y, Rochat F, Perruisseau-Carrier G, et al. (2002) Effects of oligosaccharide on the faecal flora and nonspecific immune system in elderly people. Nutr Res 22, 13-25.
3. Fuller Z, Louis P, Mihajlovski A, et al. (2007) Influence of cabbage processing methods and prebiotic manipulation of colonic microflora on glucosinolate breakdown in man. Br J Nutr 98, 364-372.
4. Kolida S, Meyer D & Gibson GR (2007) A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans. Eur J Clin Nutr 61, 1189-1195.
5. Ramnani P, Gaudier E, Bingham M, et al. (2010) Prebiotic effect of fruit and vegetable shots containing Jerusalem artichoke inulin: a human intervention study. Br J Nutr 104, 233-240.
6. Kleessen B, Schwarz S, Boehm A, et al. (2007) Jerusalem artichoke and chicory inulin in bakery products affect faecal microbiota of healthy volunteers. Br J Nutr 98, 540-549.
7. Tuohy KM, Kolida S, Lustenberger AM, et al. (2001) The pre-biotic effects of biscuits containing partially hydrolysed guar gum and fructo- oligosaccharides-a human volunteer study. Br J Nutr 86, 341-348.
8. Ramirez-Farias C, Slezak K, Fuller Z, et al. (2009) Effect of inulin on the human gut microbiota: stimulation of Bifido-bacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 101, 541-550.
9. Louis P, Young P, Holtrop G, et al. (2010) Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol 12, 304-314.
10. Firmansyah A, Pramita G, Carrie-Fassler A, et al. (2001) Improved humoral immune response to measles vaccine in infants receiving infant cereal with fructooligosaccharides. JPGN 31, A521.
11. Bakker-Zierikzee AM, Tol EA, Kroes H, et al. (2006) Faecal SIgA secretion in infants fed on pre-or probiotic infant formula. Pediatr Allergy Immunol 17, 134-140.
12. Moro G, Arslanoglu S, Stahl B, et al. (2006) A mixture of prebiotic oligosaccharids reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 91, 814-819.
13. Scholtens PAMJ, Alliet P, Raes M, et al. (2008) Faecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosac-charides and long-chain fructo-oligosaccharides. J Nutr 138, 1141-1147.
14. Seidel C, Boehm V, Vogelsang H, et al. (2007) Influence of prebiotics and antioxidants in bread on the immune system, antioxidative status and antioxidative capacity in male smokers and non-smokers. Br J Nut 97, 349-356.
15. Bunout D, Hirsch S, Pia de la Maza M, et al. (2002) Effects of prebiotics on the immune response to vaccination in the elderly. JPEN 26, 372-376.
16. Schiffrin EJ, Thomas DR, Kumar VB, et al. (2007) Systemic inflammatory markers in older persons: the effect of oral nutritional supplementation with prebiotics. J Nutr Health Aging 11, 475-479.
17. Langkamp-Henken B, Bender BS, Gardner EM, et al. (2004) Nutritional formula enhanced immune function and reduced days of symptoms of upper respiratory tract infection in seniors. J Am Geriatr Soc 52, 3-12.
18. Langkamp-Henken B, Wood SM, Herrlinger-Garcia KA, et al. (2006) Nutritional formula improved immune profiles of seniors living in nursing homes. J Am Geriatr Soc 54, 1861-1870.
19. Bunout D, Barrera G, Hirsch S, et al. (2004) Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. JPEN 28, 348-354.
20. Rafter J, Bennett M, Caderni G, et al. (2007) Dietary synbio-tics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr 85, 488-496.
21. Roller M, Clune Y, Collins K, et al. (2007) Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobac-terium lactis has minor effects on selected immune parameters in polpectomised and colon cancer patients. Br J Nutr 97, 676-684.
22. Furrie E, Macfarlane S, Kennedy A, et al. (2005) Synbiotic therapy (Bifidobacterium longum/Synergy1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54, 242-249.
23. Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, et al. (2006) Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: early results of a randomized controlled trial. World J Surg 30, 1848-1855.
24. Lomax AR & Calder PC (2009) Prebiotics, immune function, infection and inflammation: a review of the evidence. Br J Nutr 101, 633-658.
25. Cummings JH, Antoine JM, Azpiroz F, et al. (2004) PASSCLAIM-gut health and immunity. Eur J Nutr 43, Suppl. 2, II118-III73.
26. Van Loo J, Cummings J, Delzenne N, et al. (1999) Functional food properties of non-digestible oligosaccharides: a consensus report from the ENDO project (DGXII AIRII-CT94-1095). Br J Nutr 81, 121-132.
27. EFSA Panel on Dietetic Products, Nutrition and Allergies (2011) Guidance on the scientific requirements for health claims related to gut and immune function. EFSA J 9, 1984.
28. Meyer D & Stasse-Wolthuis M (2009) The bifidogenic effect of inulin and oligofructose and its consequences for gut health. Eur J Clin Nutr 63, 1277-1289.
29. Menne E, Guggenbuhl N & Roberfroid M (2000) Fn-type chicory inulin hydrolysate has a prebiotic effect in humans. J Nutr 130, 1197-1199.
30. De Preter V, Vanhoutte T, Huys G, et al. (2007) Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. Am J Physiol Gastrointest Liver Physiol 292, G358-G368.
31. Albers R, Antoine JM, Bourdet-Sicard R, et al. (2005) Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr 94, 452-481.
32. Flint HJ (2011) Obesity and the gut microbiota. J Clin Gastroenterol 45, S128-S132.
33. Tilg H & Kaser A (2011) Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 121, 2126-2132.
34. Calder PC, Ahluwalia N, Brouns F, et al. (2011) Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr 106, Suppl. S3, S1-S78.
35. Delzenne NM, Neyrinck AM & Cani PD (2011) Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact 10, Suppl. 1, S10.